Abstract
Purpose
To investigate ocular findings in a Korean population with myotonic dystrophy type 1 (DM1).
Methods
A total of 24 Korean patients with DM1, ranging in age from 4 to 71 years, were examined over a period from June 2004 to May 2014. Ophthalmologic examinations including visual acuity assessment, slit-lamp biomicroscopy, ocular motility, cycloplegic refraction, and fundus examination were performed in all patients, and brain magnetic resonance (MR) imaging was performed in 15 patients.
Results
The ocular findings, in order of decreasing prevalence, were as follows: cataract (17 patients, 71 %), myopia (22 eyes, 59 %), hyperopia (13 eyes, 35 %), ptosis (6 patients, 25 %), epiretinal membrane (5 patients, 21 %), exotropia (4 patients, 17 %), ocular motility limitations (4 patients, 17 %), blepharitis (2 patients, 8 %), pigmentary retinopathy (2 patients, 8 %), lid lag (1 patient, 4 %), esotropia (1 patient, 4 %), and myelinated nerve fiber layer (1 patient, 4 %). Five of eight patients (63 %) with CTG repeats ≥ 700 underwent cataract extraction, as did one of 13 patients (8 %) with CTG repeats < 700 (P = 0.014). All four patients who showed limited ocular motility had CTG repeats ≥ 1000. Brain MR imaging showed periventricular white matter lesions in three patients, diffuse brain atrophy in two patients, and extraocular muscle atrophy in two patients.
Conclusions
Korean patients with DM1 showed a high incidence of exotropia in comparison to Caucasian patients with DM1. Our study suggests a possible correlation between the severity of cataract and ocular motility limitation and the size of CTG repeats.
Similar content being viewed by others
References
Harper PS (1979) Myotonic dystrophy. Saunders, Philadelphia
Brook JD, McCurrach ME, Harley HG et al (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 69:385
Day JW, Ricker K, Jacobsen JF et al (2003) Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60:657–664
Ranum LP, Day JW (2004) Myotonic dystrophy: RNA pathogenesis comes into focus. American J Human Gen Am J Hum Genet 74:793–804
Diamond GR (1995) Ocular manifestations of genetic and development diseases. Curr Opin Ophthalmol 6:70–76
Bollen E, den Heyer JC, Tolsma MH et al (1992) Eye movements in myotonic dystrophy. J Neurol 115:445–450
Koca MR, Horn F, Korth M (1992) Alterations of saccadic eye movements in myotonic dystrophy. Graefes Arch Clin Exp Ophthalmol 230:437–441
Osanai R, Kinoshita M, Hirose K (2007) Eye movement disorders in myotonic dystrophy type 1. Acta Oto-laryngol 559:78–84
Verhagen WI, Huygen PL (1997) Abnormalities of ocular motility in myotonic dystrophy. J Neurol 120:1907–1909
Anastasopoulos D, Kimmig H, Mergner T et al (1996) Abnormalities of ocular motility in myotonic dystrophy. J Neurol 119:1923–1932
Ajroud-Driss S, Sufit R, Siddique T et al (2008) Oculomotor involvement in myotonic dystrophy type 2. Muscle Nerve 38:1326–1329
Wong VA, Beckingsale PS, Oley CA et al (2002) Management of myogenic ptosis. Ophthalmology 109:1023–1031
Kimizuka Y, Kiyosawa M, Tamai M et al (1993) Retinal changes in myotonic dystrophy Clinical and follow-up evaluation. Retina 13:129–135
Dreyer RF (1983) Ocular hypotony in myotonic dystrophy. Int Ophthalmol 6:221–223
Osanai R, Kinoshita M, Hirose K (1998) Saccadic slowing in myotonic dystrophy and CTG repeat expansion. J Neurol 245:674–680
Isashiki Y, Nakagawa M, Yamada H et al (1994) Ocular manifestations in mitochondrial DNA abnormalities. Nippon Ganka Gakkai Zasshi 98:3–12
Kim US, Kim JS (2009) Hwang JM. A case of myotonic dystrophy with pigmentary retinal changes. Korean J Ophthalmol 23:121–123
Bollinger KE, Kattouf V, Arthur B et al (2008) Hypermetropia and esotropia in myotonic dystrophy. J AAPOS 12:69–71
Jenkins RH (1992) Demographics: geographical variations in the prevalence and management of exotropia. Am Orthop J 42:82–87
Yoon KC, Mun GH, Kim SD et al (2011) Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008–2009. Korean J Ophthalmol 25:421–433
Kim MJ, Park KH, Kim CY et al (2014) The distribution of intraocular pressure and associated systemic factors in a Korean population: The Korea National Health and Nutrition Examination Survey. Acta Ophthalmol 92:e507–513
Raitta C, Karli P (1982) Ocular findings in myotonic dystrophy. Ann Ophthalmol 14:647–650
Ginsberg J, Hamblet J, Menefee M (1978) Ocular abnormality in myotonic dystrophy. Ann Ophthalmo 10:1021–1028
Kim TN, Lee JE, Lee EJ et al (2014) Prevalence of and factors associated with lens opacities in a Korean adult population with and without diabetes: the 2008–2009 Korea National Health and Nutrition Examination Survey. PLoS One 9, e94189
Burian HM, Burns CA (1966) Ocular changes in myotonic dystrophy. Trans Am Ophthalmol Soc 64:250–273
Osani R, Kinoshita M, Hirose K et al. (2007) Eye movement disorders in myotonic dystrophy type 1. Acta Otolaryngol Suppl.(559):78–84
Marchini C, Lonigro R, Verriello L et al (2000) Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy. Clin Genet 57:74–82
Romeo V, Pegoraro E, Ferrati C et al (2010) Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2. J Neurol 257:1246–1255
Kersten HM, Roxburgh RH, Child N et al (2014) Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1. J Neurol 261:37–44
You Q, Xu L, Jonas JB (2008) Prevalence and associations of epiretinal membranes in adult Chinese: the Beijing eye study. Eye 22:874–879
Kawasaki R, Wang JJ, Mitchell P et al (2008) Racial difference in the prevalence of epiretinal membrane between Caucasians and Asians. Br J Ophthalmmol 92:1320–132
Acknowledgments
Contributors
Design and conduct of study (JMH and KSP); collection of data (SHC); analysis and interpretation of data (SHC, HKY); preparation of manuscript (SHC, HKY, JMH, KSP); review and approval of manuscript (JMH, KSP).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding / Support
Financial support was provided by the Ministry of Education, Science and Technology in the form of the Basic Science Research Program through the National Research Foundation (NRF) of Korea (2013R1A1A2010606). The sponsor had no role in the design or conduct of this research.
Conflict of Interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; or expert testimony or patent-licensing arrangements) or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Seoul National University Bundang Hospital and with the 1964 Declaration of Helsinki. For this type of study, formal consent is not required.
Additional information
Se Hyun Choi and Hee Kyung Yang contributed equally to this work and should be considered co-first authors.
Jeong-Min Hwang and Kyung Seok Park should be considered equivalent corresponding authors.
Rights and permissions
About this article
Cite this article
Choi, S.H., Yang, H.K., Hwang, JM. et al. Ocular Findings of Myotonic Dystrophy Type 1 in the Korean Population. Graefes Arch Clin Exp Ophthalmol 254, 1189–1193 (2016). https://doi.org/10.1007/s00417-016-3266-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-016-3266-5